Decreased neurotropism of nef long terminal repeat (nef/LTR)-deleted simian immunodeficiency virus

Journal of NeuroVirology

Volumn 9, Issue 4, 2003, Pages 442-451

  Thompson, Katherine A ^a,b   Kent, Stephen J ^a,c   Gahan, Michelle E ^a,b   Purcell, Damian F J ^c   McLean, Catriona A ^a,b   Preiss, Scott ^c   Dale, C Jane ^c   Wesselingh, Steven L ^a,b,d  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d BURNET INSTITUTE   (Australia)

Author keywords

HIV associated dementia; Macaque; nef; Neuropathogenesis; Neurotropism; Simian immunodeficiency virus

Indexed keywords

NEF PROTEIN; VIRUS DNA;

ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BLOOD SAMPLING; BRAIN REGION; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; DNA EXTRACTION; FRONTAL CORTEX; GENE DELETION; HISTOPATHOLOGY; HUMAN IMMUNODEFICIENCY VIRUS; LONG TERMINAL REPEAT; MACACA; NEUROTROPISM; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INFECTION; VIRUS LOAD; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALIA; DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; MACACA; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0043031088     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280390218715     Document Type: Article

References (25)

1. Adamson DC, Dawson TM, Zink MC, Clements JE, Dawson VL (1996). Neurovirulent simian immunodeficiency virus infection induces neuronal, endothelial, and glial apoptosis. Mol Med 2: 417-428.
2. Buchbinder SP, Katz MH, Hessol NA, O'Malley PM, Homberg SD (1994). Long-term HIV-1 infection without immunologic progression. AIDS 8: 1123-1128.
3. Churchill M, De castella I, Rhodes D, McPhee DA, Deacon N (2001). Evolution of promoter activities of attenuated strains of HIV-1. In: Proceedings of 13th Annual Conference Australasian Society for HIV Medicine. Melbourne, Australia, p 50.
4. Clements JE, Anderson MG, Zink MC, Joag SV, Narayan O (1994). The SIV model of AIDS encephalopathy. Role of neurotropic viruses in diseases. In: HIV, AIDS and the brain. Price RW, Perry SW (eds). New York: Raven Press, pp 147-157.
5. Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker DJ, McPhee DA, Greenway AL, Ellett A, Chatfield C (1995). Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270: 988-991.
6. Demuth M, Czub S, Sauer U, Koutsilieri E, ten Haaft P, Heeney J, Stahl-Hennig C, ter Meulen V, Sopper S (2000). Relationship between viral load in blood, cerebrospinal fluid, brain tissue and isolated microglia with neurological disease in macaques infected with different strains of SIV. J Neuro Virol 6: 187-201.
7. Flaherty MT, Hauer DA, Mankowski JL, Zink MC, Clements JE (1997). Molecular and biological characterization of a neurovirulent molecular clone of simian immunodeficiency virus. J Virol 71: 5790-5798.
8. Iversen AK, Shpaer EG, Rodrgio AG, Hirsch MS, Walker BD, Sheppard HW, Merigan TC, Mullins JI (1995). Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic indvidual. J Virol 69: 5743-5753.
9. Jin X, Bauer DE, Tuttleton SE, Lewin S, Gettie A, Blanchard J, Irwin CE, Safrit T, Mittler J, Weinberger L, Kostrikis LG, Zhang L, Perelson AS, Ho DD (1999). Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 189: 991-998.
10. Kent SJ, Dale CJ, Preiss S, Mills J, Campagna D, Purcell DF (2001). Vaccination with attenuated simian immunodeficiency virus by DNA inoculation. J Virol 75: 11930-11934.
11. Kent SJ, Dale CJ, Preiss S, Purcell DF (2002). Evidence of recombination between 3′ and 5′ LTRs in macaques inoculated with SIV DNA. AIDS Res Hum Retroviruses 18: 227-230.
12. Kent SJ, Woodward A, Zhao A (1997). Human immunodeficiency virus type 1 (HIV-1)-specific T cell responses correlate with control of acute HIV-1 infection in macaques. J Infect Dis 176: 1188-1197.
13. Kent SJ, Zhao A, Best SJ, Chandler JD, Boyle DB, Ramshaw IA (1998). Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus. J Virol 72: 10180-10188.
14. Kestler HW, Ringler DJ, Mori K, Panicali DL, Sehgal PK, Daniel MD, Desrosiers RC (1991). Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65: 651-662.
15. Learmont JC, Geczy AF, Mills J, Ashton LJ, Raynes-Greenow CH, Garsia RJ, Dyer WB, McIntyre L, Oelrichs RB, Rhodes DI, Deacon NJ, Sullivan JS, McPhee DA, Crowe S, Solomon AE, Chatfield C, Cooke IR, Blasdall S, Kuipers H (1999). Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort. N Eng J Med 340: 1715-1722.
16. Mankowski JL, Flaherty MT, Spelman JP, Hauer DA, Didier PJ, Amedee AM, Murphey-Corb M, Kirstein LM, Munoz A, Clements JE, Zink MC (1997). Pathogenesis of simian immunodeficiency virus encephalitis: viral determinants of neurovirulence. J Virol 71: 6055-6060.
17. Mariani R, Kirchhoff F, Greenough TC, Sullivan JL, Desrosiers RC, Skowronski J (1996). High frequency of defective nef alleles in a long-term survivor with non-progressive human immunodeficiency virus type 1 infection. J Virol 70: 7752-7764.
18. Rhodes D, Solomon A, Bolton W, Wood J, Sullivan J, Learmont J, Deacon N (1999). Identification of a new recipient in the Sydney Blood Bank Cohort: a long-term HIV type 1-infected seroindeterminate individual. AIDS Res Hum Retroviruses 15: 1433-1439.
19. Rhodes DI, Ashton LJ, Solomon AE, Carr A, Cooper D, Kaldor J, Deacon NJ (2000). Characterization of three nef defective human immunodeficiency virus type 1 strains associated with long-term nonprogression. J Virol 74: 10581-10588.
20. Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen B, McArthur JC, The Multicenter ACS (2001). HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology 56: 257-260.
21. Salvi R, Garbuglia. AR, Di Caro A, Pulciani S, Montella F, Benedetto A (1998). Grossly defective nef gene sequences in a human immunodeficiency virus type-1 seropositive long-term nonprogressor. J Virol 72: 3646-3657.
22. von Herrath M, Oldstone MBA, Fox HS (1995). Simian immunodeficiency virus (SIV)-specific CTL in cerebrospinal fluid and brains of SIV-infected rhesus macaques. J Immunol 154: 5582-5589.
23. Zink MC, Amedee AM, Mankowski JL, Craig L, Didier PJ, Carter DL, Munoz A, Murphey-Corb M, Clements JE (1997). Pathogenesis of SIV encephalitis. Selection and replication of neurovirulent SIV. Am J Pathol 151: 793-803.
24. Zink MC, Spelman JP, Robinson RB, Clements JE (1998). SIV infection of macaques-modeling the progression to AIDS dementia. J NeuroVirol 4: 249-259.
25. Zink MC, Suryanarayana K, Mankowski JL, Shen A, Piatak M, Spelman JP, Carter DL, Adams RJ, Lifson JD, Clements JE (1999). High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis. J Virol 73: 10480-10488.